Authors: Shuchismita Dutta* (Rutgers University, NJ), Kimberley Cortes (Kennesaw State University, GA), Henry Jakubowski (College of St. Benedict, St. John's University, MN), Melanie Lenahan (Raritan Valley Community College, NJ), David Marcey (California Lutherian University, CA), Patricia Marsteller (Emory University, GA), and Cassidy Terrell (University of Minnesota, Rocester MN); *contact: sdutta@rcsb.rutgers.edu
Citation and Adaptations: doi:10.25334/H82J-3C28
Work funded by NSF grant # 1827011
Video source: National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services. |
Complete Case for students of: |
Why use this case? | |
Prior to case discussion (Homework): Watch video and answer the questions in the Preparation section |
Resources to learn more |
Section I: Nicholas' Pain Crises | ||
Chemistry | 2. Getting to Structure: | Understanding Sickle Cell Disease (SCD): A Classroom scene |
3. Molecular Exploration: | The Sickle Cell Mutant; Nicholas’ Pain Crises | |
4. Assessment: | What if there was an additional mutation? | |
Biology | 2. Getting to Structure: | Understanding Sickle Cell Disease (SCD): Read and Learn |
3. Molecular Exploration: | The Sickle Cell Mutant; Nicholas’ Pain Crises | |
4. Assessment: | What if there was an additional mutation? | |
Section II: Hydroxyurea to the Rescue | ||
Biology | 2. Getting to Structure: | What does Hydroxyurea do? |
3. Molecular Exploration: | Fetal and Adult Hemoglobin; Changing Nicholas’ life | |
4. Assessment: | Gene Therapy for SCD | |
Section III: Bridgette's wish | ||
Biology | 2. Getting to Structure: | Approaches to manage SCD |
3. Molecular Exploration: | Oxy vs Deoxy hemoglobin S; FDA Approves Voxelotor | |
4. Assessment: | Gene Therapy for SCD |
Authors+Date; DOI | Title | Adaptation | Notes |